Valvular Heart Disease

Valvular Heart Disease is a topic covered in the Washington Manual of Medical Therapeutics.

To view the entire topic, please or .

The Washington Manual of Medical Therapeutics helps you diagnose and treat hundreds of medical conditions. Consult clinical recommendations from a resource that has been trusted on the wards for 50+ years. Explore these free sample topics:

-- The first section of this topic is shown below --

The 2014 and updated 2017 American Heart Association/American College of Cardiology (AHA/ACC) Guidelines describe different stages in the progression of valvular heart disease (VHD).1,2

  • Stage A (at risk): patients with risk factors for development of VHD.
  • Stage B (progressive): patients with progressive VHD (mild to moderate severity and asymptomatic).
  • Stage C (asymptomatic severe): asymptomatic patients who meet criteria for severe VHD.
    • C1: asymptomatic patients with a compensated left and right ventricle.
    • C2: asymptomatic patients with decompensation of the left or right ventricle.
  • Stage D (symptomatic severe): patients who have developed symptoms as a result of VHD.

-- To view the remaining sections of this topic, please or --

The 2014 and updated 2017 American Heart Association/American College of Cardiology (AHA/ACC) Guidelines describe different stages in the progression of valvular heart disease (VHD).1,2

  • Stage A (at risk): patients with risk factors for development of VHD.
  • Stage B (progressive): patients with progressive VHD (mild to moderate severity and asymptomatic).
  • Stage C (asymptomatic severe): asymptomatic patients who meet criteria for severe VHD.
    • C1: asymptomatic patients with a compensated left and right ventricle.
    • C2: asymptomatic patients with decompensation of the left or right ventricle.
  • Stage D (symptomatic severe): patients who have developed symptoms as a result of VHD.

There's more to see -- the rest of this entry is available only to subscribers.